← FDA Drug Approvals (Drugs@FDA)

TRADJENTA

NDA · New Drug Application · Sponsor: BOEHRINGER INGELHEIM · Approved 2011-05-02

Drug application

FDA Application #
NDA201280
Application type
New Drug Application
Brand name
TRADJENTA
Generic name
LINAGLIPTIN
Active ingredients
LINAGLIPTIN
Dosage form
TABLET
Route
ORAL
Marketing status
Prescription
Sponsor
BOEHRINGER INGELHEIM
Manufacturer
Boehringer Ingelheim Pharmaceuticals, Inc.
First approval
2011-05-02

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown